Keratitis
36
2
2
22
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
5.6%
2 terminated out of 36 trials
91.7%
+5.2% vs benchmark
28%
10 trials in Phase 3/4
27%
6 of 22 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 22 completed trials
Clinical Trials (36)
Pattern of Microbial Keratitis in Assiut University Hospital
Complex Ocular Infection, Optimization of Microbiological Diagnosis
Automated Quantitative Ulcer Analysis Study
The Effects of a Large Language Model on Clinical Questioning Skills
Use of a Biological Lens of Amniotic Membrane (LV-Visio-AMTRIX) in the Treatment of Treatment-Resistant Keratitis
Safety of Overnight Corneal Reshaping Lenses
Evaluation of Safety and Efficacy of rhNGF in Patients With Stage 2 and 3 Neurotrophic Keratitis.
Effect of IKERVIS® Eye Drops Once Daily on the Quality of Vision in Dry Eye Disease Patients With Severe Keratitis
Evaluation of Next-Generation Sequencing-based Metabarcoding Versus Culturing for Microbiological Assessment in Infectious Keratitis
Deep Learning for the Discrimination Among Different Types of Keratits: a Nationwide Study
Efficacy of Mutilayered Fresh Amnoitic Membrane Transplantation in Resistant Fungal Keratitis
Ozone-based Eye Drops as Adjuvant Therapy in Microbial Keratitis
Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Refractory Corneal Ulcers
Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Previously Untreated Corneal Ulcers
Impact of Acthar on Everyday Life of Participants With Severe Keratitis
Efficacy and Safety Assessment of T4020 Versus Vehicule in Patients With Chronic Neurotrophic Keratitis or Corneal Ulcer
Tolerance to Light for Patients Suffering From Keratitis
Multiplex Strip Polymerase Chain Reaction for Diagnosis of Eye Infection Diseases From Corneal Scraping Samples
Robotic Surgery of the Ocular Surface
Tear Lipid Layer Thickness Changes With Use of Emollient and Non-Emollient Eye Drops